RxDoctor Payments Data

Mimi Balch, MD

Family Medicine · Ocala, FLNPI 1396811410

Payments from drug & device makers

$1,047in general payments, 2019–2025

Across 57 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$280
  • Lilly USA, LLC$93
  • Pfizer$87
  • Exact Sciences$84
  • Phathom Pharmaceuticals, Inc.$80
  • Teva Pharmaceuticals USA, Inc.$74
  • plus $349 from 11 others

What the payments were for

  • Food & beverage$1,047100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,047 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$306,134
Medicare patients
656
Services billed
12,201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin83$118,972
OzempicSemaglutide91$116,023
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$85,437
FarxigaDapagliflozin Propanediol63$66,107
MounjaroTirzepatide53$57,303
Victoza 3-PakLiraglutide11$21,461
XareltoRivaroxaban21$20,656
JanuviaSitagliptin Phosphate15$20,285
MyrbetriqMirabegron16$17,360
TrulicityDulaglutide15$14,743
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$10,630
Breo ElliptaFluticasone/Vilanterol18$10,484
Rosuvastatin Calcium495$6,513
Atorvastatin Calcium671$6,197
Doxepin Hcl13$5,907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$39$118,97283 claims
Novo NordiskOzempic$32$116,02391 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$15$106,551113 claims
Lilly USA, LLCMounjaro, Trulicity$93$72,04668 claims
AstraZenecaFarxiga, Symbicort$71$70,24578 claims
MerckJanuvia$12$20,28515 claims
Astellas Pharma US IncMyrbetriq$25$17,36016 claims
AbbVieSynthroid$280$2,82049 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →